JP2022539583A5 - - Google Patents
Info
- Publication number
- JP2022539583A5 JP2022539583A5 JP2022500047A JP2022500047A JP2022539583A5 JP 2022539583 A5 JP2022539583 A5 JP 2022539583A5 JP 2022500047 A JP2022500047 A JP 2022500047A JP 2022500047 A JP2022500047 A JP 2022500047A JP 2022539583 A5 JP2022539583 A5 JP 2022539583A5
- Authority
- JP
- Japan
- Prior art keywords
- jepotidacin
- pharmaceutically acceptable
- doxycycline
- acceptable salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962870990P | 2019-07-05 | 2019-07-05 | |
| US62/870,990 | 2019-07-05 | ||
| US202062985465P | 2020-03-05 | 2020-03-05 | |
| US62/985,465 | 2020-03-05 | ||
| PCT/EP2020/068754 WO2021004910A1 (en) | 2019-07-05 | 2020-07-03 | Combination for the treatment of infections caused by mycoplasma genitalium |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539583A JP2022539583A (ja) | 2022-09-12 |
| JP2022539583A5 true JP2022539583A5 (https=) | 2023-06-13 |
| JP7638263B2 JP7638263B2 (ja) | 2025-03-03 |
Family
ID=71579551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500047A Active JP7638263B2 (ja) | 2019-07-05 | 2020-07-03 | マイコプラズマ・ジェニタリウムによって引き起こされる感染症の治療のための組合せ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220257615A1 (https=) |
| EP (1) | EP3993796B1 (https=) |
| JP (1) | JP7638263B2 (https=) |
| CN (1) | CN114173789A (https=) |
| BR (1) | BR112021024845A2 (https=) |
| CA (1) | CA3143619A1 (https=) |
| ES (1) | ES2981617T3 (https=) |
| WO (1) | WO2021004910A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11917094B2 (en) * | 2021-02-01 | 2024-02-27 | Aptiv Technologies Limited | Automatic control of smartphone driver mode using ultra-wideband communication |
| EP4288035A1 (en) * | 2021-02-05 | 2023-12-13 | GlaxoSmithKline Intellectual Property Development Limited | Oral solid dose formulations |
| JP2025532252A (ja) | 2022-09-26 | 2025-09-29 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | 処置方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008240764C1 (en) * | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
| US9993469B2 (en) | 2013-05-28 | 2018-06-12 | Morphochem Aktiengesellschaft Für Kombinatorishe Chemie | Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections |
| US10702521B2 (en) * | 2014-08-22 | 2020-07-07 | Glaxosmithkline Intellectual Property Development Limited | Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones |
| WO2018195098A1 (en) * | 2017-04-17 | 2018-10-25 | Ohio State Innovation Foundation | Type ii topoisomerase inhibitors and methods of making and using thereof |
-
2020
- 2020-07-03 US US17/619,367 patent/US20220257615A1/en not_active Abandoned
- 2020-07-03 EP EP20739585.6A patent/EP3993796B1/en active Active
- 2020-07-03 JP JP2022500047A patent/JP7638263B2/ja active Active
- 2020-07-03 ES ES20739585T patent/ES2981617T3/es active Active
- 2020-07-03 WO PCT/EP2020/068754 patent/WO2021004910A1/en not_active Ceased
- 2020-07-03 BR BR112021024845A patent/BR112021024845A2/pt unknown
- 2020-07-03 CN CN202080049062.5A patent/CN114173789A/zh active Pending
- 2020-07-03 CA CA3143619A patent/CA3143619A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539583A5 (https=) | ||
| MX2010006326A (es) | Comprimidos de desintegracion oral que comprenden difenhidramina. | |
| CN1233181A (zh) | 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法 | |
| JP6313414B2 (ja) | 外傷性傷害の処置におけるレボセチリジン及びモンテルカストの使用 | |
| US8536143B2 (en) | Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals | |
| RU2018107150A (ru) | Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью | |
| JP2005501862A (ja) | １回限りの投与量のアジスロマイシン | |
| CN120129522A (zh) | 用于治疗化脓性汗腺炎的方法和组合物 | |
| JP2022551691A5 (https=) | ||
| JP2019516797A (ja) | 鼻詰まりを治療／予防するためのカルボン酸 | |
| Ullah et al. | Bioavailability of antibiotics and their toxicity | |
| Jodh et al. | An Updated Review on Doxycycline | |
| JP2025502442A5 (https=) | ||
| JP2023515880A5 (https=) | ||
| JP2025506201A5 (https=) | ||
| Teo et al. | Asplenic fulminant sepsis secondary to a dog bite complicated by toxic epidermal necrolysis/Stevens-Johnson syndrome | |
| WO2023066330A1 (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| IT201800002457A1 (it) | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie | |
| JP2024527715A5 (https=) | ||
| JP2013507443A (ja) | 薬学的組成物 | |
| Houglum et al. | Drugs for treating infections | |
| RU2391977C2 (ru) | Способ лечения острых форм бактериальных вагинитов | |
| CN114375200A (zh) | 治疗传染病的药物和方法 | |
| WO1999043333A1 (en) | Therapeutic and prophylactic uses of negatively charged substituted disaccharides | |
| US20210268075A1 (en) | Pharmaceutical composition and method of treatment using serratiopeptidase, mannose or its derivative, and optionally antinfection agents |